title: 18F-FDG PET/CT of cervical carcinoma.
abstract: OBJECTIVE
  This article outlines the role of FDG PET/CT in patients with cervical carcinoma for evaluating tumor extent, assessing treatment response, and detecting disease recurrence.
  
  
  CONCLUSIONS
  There is increasing evidence that FDG PET/CT has a role in the primary evaluation of cervical carcinoma-in particular, for evaluating lymph node status and distant metastatic disease. PET/CT is also helpful to determine prognosis, assess treatment response, and evaluate disease recurrence.
authors.affiliation: Department of Nuclear Medicine, St. James's University Hospital, Leeds, United Kingdom. chirag.patel@leedsth.nhs.uk
authors.forename: Chirag N
authors.initials: CN
authors.lastname: Patel
authors.forename: Sarfraz A
authors.initials: SA
authors.lastname: Nazir
authors.forename: Zubair
authors.initials: Z
authors.lastname: Khan
authors.forename: Fergus V
authors.initials: FV
authors.lastname: Gleeson
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Bradley
mesh_terms: D002277:Carcinoma / Q000175:diagnosis*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18